Simon Stott

3.7k total citations · 1 hit paper
34 papers, 1.9k citations indexed

About

Simon Stott is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Simon Stott has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Simon Stott's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Nuclear Receptors and Signaling (9 papers) and Pluripotent Stem Cells Research (8 papers). Simon Stott is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Nuclear Receptors and Signaling (9 papers) and Pluripotent Stem Cells Research (8 papers). Simon Stott collaborates with scholars based in United Kingdom, United States and Sweden. Simon Stott's co-authors include Roger A. Barker, Richard Wyse, Kevin McFarthing, Gary Rafaloff, Enrique M. Toledo, Peter Lönnerberg, Sten Linnarsson, Daniel Gyllborg, Ernest Arenas and Jesper Ryge and has published in prestigious journals such as Cell, Journal of Neuroscience and The EMBO Journal.

In The Last Decade

Simon Stott

34 papers receiving 1.9k citations

Hit Papers

Molecular Diversity of Midbrain Development in Mouse, Hum... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Stott United Kingdom 22 982 605 458 289 273 34 1.9k
W. Michael Zawada United States 23 821 0.8× 801 1.3× 369 0.8× 421 1.5× 192 0.7× 35 1.8k
Maurizio D’Antonio Italy 26 1.2k 1.2× 1.5k 2.5× 393 0.9× 383 1.3× 252 0.9× 47 2.6k
Steven Petratos Australia 27 891 0.9× 949 1.6× 245 0.5× 604 2.1× 354 1.3× 71 2.5k
Zachary P. Wills United States 18 1.3k 1.3× 838 1.4× 273 0.6× 154 0.5× 106 0.4× 28 2.1k
Ikuko Mizuta Japan 26 736 0.7× 762 1.3× 891 1.9× 121 0.4× 478 1.8× 98 2.0k
Serena Giannelli Italy 24 1.3k 1.3× 516 0.9× 216 0.5× 233 0.8× 290 1.1× 33 1.9k
Andrii Domanskyi Finland 20 597 0.6× 515 0.9× 309 0.7× 161 0.6× 182 0.7× 39 1.4k
Jacqueline A. Sluijs Netherlands 22 1.4k 1.4× 471 0.8× 354 0.8× 364 1.3× 472 1.7× 42 2.4k
Susanna Amadio Italy 31 742 0.8× 474 0.8× 523 1.1× 217 0.8× 836 3.1× 65 2.7k

Countries citing papers authored by Simon Stott

Since Specialization
Citations

This map shows the geographic impact of Simon Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Stott more than expected).

Fields of papers citing papers by Simon Stott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Stott. The network helps show where Simon Stott may publish in the future.

Co-authorship network of co-authors of Simon Stott

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Stott. A scholar is included among the top collaborators of Simon Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Stott. Simon Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McFarthing, Kevin, Gary Rafaloff, Brian Fiske, et al.. (2023). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update. Journal of Parkinson s Disease. 13(4). 427–439. 53 indexed citations
2.
Birtele, Marcella, Petter Storm, Yogita Sharma, et al.. (2022). Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain. Development. 149(23). 19 indexed citations
3.
Stott, Simon, Yoav Y. Broza, Alaa Gharra, et al.. (2022). The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease. Journal of Parkinson s Disease. 12(3). 993–1002. 9 indexed citations
4.
McFarthing, Kevin, Gary Rafaloff, Marco A. S. Baptista, Richard Wyse, & Simon Stott. (2021). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update. Journal of Parkinson s Disease. 11(3). 891–903. 50 indexed citations
5.
McFarthing, Kevin, et al.. (2020). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020. Journal of Parkinson s Disease. 10(3). 757–774. 99 indexed citations
6.
Stott, Simon, Suzanne J. Randle, Sara Al Rawi, et al.. (2019). Loss of FBXO7 results in a Parkinson's‐like dopaminergic degeneration via an RPL23–MDM2–TP53 pathway. The Journal of Pathology. 249(2). 241–254. 22 indexed citations
7.
Stott, Simon, et al.. (2019). Hyperosmotic stress induces cell-dependent aggregation of α-synuclein. Scientific Reports. 9(1). 2288–2288. 14 indexed citations
8.
Raha‐Chowdhury, Ruma, James W. Henderson, Animesh Alexander Raha, et al.. (2017). Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome. Journal of Alzheimer s Disease. 61(3). 1143–1162. 24 indexed citations
9.
Li, Bingsi, Enrique M. Toledo, Pia Rivetti di Val Cervo, et al.. (2016). A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease. The EMBO Journal. 35(18). 1963–1978. 84 indexed citations
10.
Raha, Animesh Alexander, James W. Henderson, Simon Stott, et al.. (2016). Neuroprotective Effect of TREM-2 in Aging and Alzheimer’s Disease Model. Journal of Alzheimer s Disease. 55(1). 199–217. 75 indexed citations
11.
Roybon, Laurent, Teresa L. Mastracci, Joyce Li, et al.. (2015). The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1. PLoS ONE. 10(6). e0128035–e0128035. 8 indexed citations
12.
Schwab, Laetitia, et al.. (2015). Dopamine and Huntington’s disease. Expert Review of Neurotherapeutics. 15(4). 445–458. 54 indexed citations
13.
Raha‐Chowdhury, Ruma, Animesh Alexander Raha, Jingwei Zhao, Simon Stott, & Adrian Bomford. (2014). Iron regulatory protein hepcidin present in embryonic brain and increased in the glial scar after mechanical injury. 5. 1 indexed citations
14.
Stott, Simon & Roger A. Barker. (2013). Time course of dopamine neuron loss and glial response in the 6‐OHDA striatal mouse model of Parkinson's disease. European Journal of Neuroscience. 39(6). 1042–1056. 109 indexed citations
15.
Ali, Fahad, Simon Stott, & Roger A. Barker. (2013). Stem cells and the treatment of Parkinson's disease. Experimental Neurology. 260. 3–11. 22 indexed citations
16.
Roybon, Laurent, Tord Hjalt, Simon Stott, et al.. (2009). Neurogenin2 Directs Granule Neuroblast Production and Amplification while NeuroD1 Specifies Neuronal Fate during Hippocampal Neurogenesis. PLoS ONE. 4(3). e4779–e4779. 122 indexed citations
17.
Kornum, Birgitte Rahbek, Simon Stott, Bengt Mattsson, et al.. (2009). Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain. Experimental Neurology. 222(1). 70–85. 22 indexed citations
18.
Liuba, Karina, Cornelis Jan Pronk, Simon Stott, & Sten Eirik W. Jacobsen. (2008). Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors. Blood. 113(19). 4790–4798. 7 indexed citations
19.
Nygren, Jens, Karina Liuba, Martin Breitbach, et al.. (2008). Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nature Cell Biology. 10(5). 584–592. 133 indexed citations
20.
Krishnamurthi, Rita, Simon Stott, Richard L. M. Faull, et al.. (2004). N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport. 15(10). 1601–1604. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026